PMI points to an impressive $14.1 billion by 2032, with a steady CAGR of 6.4%

purchasing managers index

purchasing managers index

The viral gastroenteritis market covers by type (rotavirus and norovirus), by drug (antacids, antibiotics, laxatives, and antiperistaltics), by diagnostic (rapid stool test and physical examination), by end use (hospital , diagnostic centers, clinics and others) and regional forecasts, 2022-2032.

Covina, November 10, 2023 (GLOBE NEWSWIRE) — Viral Gastroenteritis Market Report Overview:

Viral gastroenteritis, often called the stomach flu, is a common illness caused by a viral infection that affects the stomach and intestines. Viruses that cause viral gastroenteritis include norovirus, rotavirus, adenovirus, and astrovirus. The viral gastroenteritis market primarily includes pharmaceuticals, diagnostics, and supportive care products and services related to the prevention, treatment, and management of the disease.

Advantages of viral gastroenteritis: this Viral Gastroenteritis Market Raise awareness about the causes, symptoms and prevention of disease. This can improve hygiene practices, which can help reduce the spread of viruses and reduce the incidence of disease.

Disadvantages of viral gastroenteritis: There are no specific antiviral drugs for most viral gastroenteritis infections, although there are medications to control symptoms. Treatment focuses primarily on supportive care and fluid replacement.



forecast period

2022 – 2032

Booked in 2022

$7.6 billion

Expected to be 2032

$14.1 billion



Major recent highlights:

  • In March 2023, BioPerfectus launched 10 new real-time PCR kits for diagnostic solutions for gastrointestinal infectious diseases. The company may offer total PCR solutions for use with extraction solutions and PCR equipment for identifying gastrointestinal (GI) infections.

Get a free sample research report packed with the latest industry insights:

Emerging Trends and Innovations in Viral Gastroenteritis Market:

In the viral gastroenteritis market, emerging trends and innovations are shaping the landscape. Advances in vaccine development offer hope for prevention, while improved diagnostic methods are increasing accuracy. New antiviral treatments target specific strains, and public health campaigns focus on hygiene and sanitation. Telemedicine facilitates remote patient management, and genomic monitoring informs prevention strategies, driving the market toward more efficient and effective solutions.

Key factors driving economic growth Viral Gastroenteritis Market:

  • Increased prevalence of disease: The increasing incidence of viral gastroenteritis cases globally has stimulated market demand.

  • Research investment: Continuous research efforts in innovative treatments and diagnostics drive market growth.

  • promotional activity: Public awareness initiatives regarding hygiene and vaccination have spurred demand for gastroenteritis-related products.

  • skill improved: Continuous improvements in diagnostics and treatments increase market efficiency.

  • governmental support: Supportive healthcare policies and vaccination programs strengthen market adoption.

  • Higher medical expenses: Rising healthcare spending is enabling patients to access advanced gastroenteritis treatments, thereby driving market growth.

Challenges of Viral Gastroenteritis Market:

In the viral gastroenteritis market, challenges include risk of contamination from various environments, diagnostic complexity due to different symptoms and strains, limited availability of specific treatments, complexity of vaccine development, social challenges related to hygiene and awareness , insufficient medical infrastructure in some areas, and the evolving nature of the virus, requiring adaptive solutions for effective disease management. Overcoming these challenges requires collaboration in research, healthcare infrastructure improvements, and public awareness campaigns.

Viral Gastroenteritis Market Opportunities:

The viral gastroenteritis market offers significant opportunities in vaccine development, advanced diagnostics, and public health campaigns. Investments in telemedicine services, collaborative research efforts and medical infrastructure development further enhance disease prevention, timely intervention and overall management. Seizing these opportunities could enable significant advances in gastroenteritis prevention and treatment strategies, ultimately benefiting patients and healthcare providers.

Download PDF brochure:

Top players in the viral gastroenteritis market:

Viral Gastroenteritis Market: Growth Factors

  1. Increased prevalence of disease: Rising cases of viral gastroenteritis globally are driving the market growth, requiring advanced diagnostic and therapeutic solutions.

  2. skill improved: Continuous innovation in diagnostic tools and treatments improves market efficiency, enabling accurate diagnosis and effective management.

  3. Research and development: Ongoing research initiatives focused on developing vaccines and targeted therapies are driving market expansion, providing new avenues for disease prevention and treatment.

  4. promotional activity: Public awareness campaigns emphasizing hygiene, sanitation and vaccination play a vital role in disease prevention, resulting in increased demand for gastroenteritis-related products and services.

  5. Government initiatives: Supportive government policies, research funding, and healthcare infrastructure development initiatives have further boosted the market, ensuring improved patient care and disease management.

Some key highlights of the report:

Market growth forecast: The viral gastroenteritis market size will be US$7.6 billion in 2022 and is expected to reach US$14.1 billion by 2032, with a compound annual growth rate expected to be 6.4%.

The viral gastroenteritis market is driven by segmentation by rotavirus and norovirus types, diversified drugs, and diagnostic methods. Significant growth is expected from 2022 to 2032, driven by continued advancements in technology. Major players such as Abbott and Valeant Pharmaceuticals lead the industry. Emerging trends in vaccine development, diagnostic improvements, and telemedicine adoption shape the market, while challenges such as contamination risks and evolving viruses require adaptive solutions. Opportunities for advanced diagnostics, public health campaigns, and telemedicine services facilitate comprehensive disease prevention and management strategies.

If you have any questions or customization before purchasing:

Explore more insights:


follow us:

LinkedIn | Twitter | Facebook |Youtube

CONTACT: Shweta R Prophecy Market Insights U.S.: +1 860 531 2574 APAC: +917775049802 Email- Web:

Source link

Leave a Comment